ADAM10 and head and neck squamous cell carcinoma: The ADAM‐10 mRNA level was significantly higher in the clinical stage II of HNSCC compared to other clinical stages (all p < 0.05) (Figure 1C) but did not associate with the N statuses (Figure 1D).